Company MYnd Analytics Inc Nasdaq
Equities
US62857N2027
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 18 | 100.0 % | -10.77% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Sekulich
PSD | President | 59 | 01/19/01 |
Willis Lee
CHM | Chairman | 64 | 17/19/17 |
Yasushi Nagasaki
DFI | Director of Finance/CFO | 57 | 01/11/01 |
Mark Diamond
CIO | Chief Investment Officer | - | - |
Charles Stark
CTO | Chief Tech/Sci/R&D Officer | 68 | 01/13/01 |
Lan T. Tran
ADM | Chief Administrative Officer | 48 | 17/19/17 |
Dale E. Short
SEC | Corporate Secretary | - | 01/18/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Peu Zen
BRD | Director/Board Member | 71 | 17/19/17 |
Willis Lee
CHM | Chairman | 64 | 17/19/17 |
Ian Zwicker
BRD | Director/Board Member | 77 | 17/19/17 |
George Sekulich
PSD | President | 59 | 01/19/01 |
Seah LIm
BRD | Director/Board Member | 66 | 04/22/04 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 53,637,554 | 25,870,168 ( 48.23 %) | 0 | 48.23 % |
Company contact information
Emmaus Life Sciences, Inc.
21250 Hawthorne Boulevard Suite 800
90503, Torrance
+
http://www.emmausmedical.com![address MYnd Analytics Inc](https://cdn.zonebourse.com/static/address/62120064.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+49.41% | 56.95B | |
+41.65% | 40.26B | |
-6.72% | 39.32B | |
-5.96% | 28.37B | |
+12.99% | 26.45B | |
-19.82% | 19.41B | |
+32.35% | 12.54B | |
-0.08% | 12.15B | |
+25.18% | 12.21B |